metricas

Annals of Hepatology

Suggestions
Annals of Hepatology
Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option
Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more
Follow us
Alert
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2024
4.4
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2025
9.6
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2025
1.446
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2025
1.378
Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more
Time to first decision
8 days
View more metrics
Hide
Last published articles
The association of frailty with cardiovascular diseases and mortality in metabolic dysfunction-associated steatotic liver disease
Fuyi Ma, Huanyu Wang, Kang Wan, Yuan Li, Yuhang Chen, Ru Wang
Ann Hepatol. 2026;31: 102214
Full text access
Making metabolic dysfunction-associated steatotic liver disease medicines affordable: Lessons from hepatitis C
Khalid M. AlNaamani, Mohamed El-Kassas, Zobair M. Younossi
Ann Hepatol. 2026;31: 102213
Full text access
Latest issue
Issue
Cover Vol. 31. Issue 2. (In progress) Vol. 31. Issue 2. (In progress)
(July - December 2026)
This issue is in progress but contains articles that are final and fully citable.
Editorial
Cirrhotic cardiomyopathy impact goes global! The South American experience
Murray Coetzee, Manhal Izzy
Ann Hepatol. 2026;31: 102202
Full text access
Making metabolic dysfunction-associated steatotic liver disease medicines affordable: Lessons from hepatitis C
Khalid M. AlNaamani, Mohamed El-Kassas, Zobair M. Younossi
Ann Hepatol. 2026;31: 102213
Full text access
Opinions
Original articles
Is FIB-4 the right tool for screening for liver fibrosis?
Leen J.M. Heyens, Demi P.A. van Malde, Gediz Dogay Us, Francesco Innocenti, Mathieu Struyve, Christophe Van Steenkiste, Sven Francque, Geert Robaeys, ... the MASLD research group
Ann Hepatol. 2026;31: 102176
Full text access
View latest issue View all issues
Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Longitudinal health-related quality of life and associated factors in autoimmune liver diseases
Dami Ko, Vilas Patwardhan, Natalia Rojas-Amaris, Victoria Abadi-Ron, Ana Marenco-Flores, Romelia Barba, Esli Medina-Morales, Leandro Sierra, ... Alan Bonder
Full text access
Uncorrected Proof. Available online 8 June 2026
Quantifying long-term outcomes and risks for living liver donors: a review of the current global experience
Ashwin Rammohan, Madhukar S. Patel, Ramkiran Cherukuru, Lauren E. Matevish, Dong-Hwan Jung, Parsia A. Vagefi, Mohamed Rela
Full text access
Uncorrected Proof. Available online 8 June 2026
View all Ahead of print
Editorial Board
Norberto C. Chávez-Tapia
Norberto C. Chávez-Tapia, MD, PhD
Fundación Clínica Médica Sur, Mexico City, Mexico
View editorial board
All issues
portada-Vol. 31. Issue 2. (In progress)
July - December
Volume 31 . Issue. 2
In progress
portada-Vol. 31. Issue 1.
January - June
Volume 31 . Issue. 1
portada-Vol. 30. Issue 2.
July - December
Volume 30 . Issue. 2
portada-Vol. 30. Issue 1.
January - June
Volume 30 . Issue. 1
View all issues
Supplements
portada-Vol. 30. Issue  S2.
September
Volume 30. Issue. S2
Abstracts of the 2025 Annual Meeting of the ALEH
portada-Vol. 30. Issue  S1.
April
Volume 30. Issue. S1
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
portada-Vol. 29. Issue  S3.
December
Volume 29. Issue. S3
Abstracts of the 2024 Annual Meeting of the ALEH
portada-Vol. 29. Issue  S2.
February
Volume 29. Issue. S2
Abstracts Asociación Mexicana del Hígado (AMH) 2023
View all supplements
Instructions for authors
Most often read
Original article
Yuan He, Fan Zhang, Zixuan Zhang, Xianwen Zhang, Yifei Zhong
10.1016/j.aohep.2025.102115
Ann Hepatol. 2026;31:
This article has been read 28.834 times
View all Most Often read articles